Marko Poglitsch
Impact in
-
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Renin-Angiotensin System Studies 54
-
- Hormonal Regulation and Hypertension 10
- Co-authors
- Marcus D. Säemann (23 shared papers)Walter Hermann Hörl (10 shared papers)Thomas Weichhart (10 shared papers)Maximilian Zeyda (6 shared papers)Oliver Domenig (32 shared papers)Thomas M. Stulnig (5 shared papers)Markus Hengstschläger (3 shared papers)Margit Rosner (2 shared papers)
- Journals
- Hypertension (11 papers)Scientific Reports (6 papers)Journal of Hypertension (4 papers)Journal of the American Heart Association (3 papers)Journal of the American College of Cardiology (3 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Marko Poglitsch
92 papers receiving 4.4k citations
Marko Poglitsch's Hit Papers
Peers
Comparison fields: 5 of 86
- Cardiology and Cardiovascular Medicine 1.3k
- Infectious Diseases 523
- Immunology 285
- Endocrinology, Diabetes and Metabolism 206
- Aging 16
Countries citing papers authored by Marko Poglitsch
This map shows the geographic impact of Marko Poglitsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Poglitsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Poglitsch more than expected).
Fields of papers citing papers by Marko Poglitsch
This network shows the impact of papers produced by Marko Poglitsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Poglitsch. The network helps show where Marko Poglitsch may publish in the future.
Co-authors
The 25 scholars most cited alongside Marko Poglitsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response Hit paper breakdown → | 2008 | 699 |
| 2 | 2020 | 327 | |
| 3 | 2013 | 309 | |
| 4 | 2019 | 272 | |
| 5 | 2010 | 195 | |
| 6 | 2017 | 165 | |
| 7 | 2017 | 155 | |
| 8 | 2011 | 126 | |
| 9 | 2019 | 98 | |
| 10 | 2021 | 97 | |
| 11 | 2012 | 95 | |
| 12 | 2010 | 87 | |
| 13 | 2005 | 84 | |
| 14 | 2016 | 79 | |
| 15 | 2017 | 79 | |
| 16 | 2012 | 72 | |
| 17 | 2018 | 57 | |
| 18 | 2020 | 55 | |
| 19 | 2017 | 54 | |
| 20 | 2020 | 53 |
About Marko Poglitsch
Marko Poglitsch is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Immunology, Obstetrics and Gynecology and Infectious Diseases, having authored 94 papers that have together received 4.4k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (54 papers), Hormonal Regulation and Hypertension (10 papers), Pregnancy and preeclampsia studies (2 papers), T-cell and B-cell Immunology (2 papers), Cholesterol and Lipid Metabolism (1 paper), Apelin-related biomedical research (1 paper), Cytomegalovirus and herpesvirus research (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.3k citations), Infectious Diseases (523 citations), Immunology (285 citations), Endocrinology, Diabetes and Metabolism (206 citations) and Aging (16 citations). Marko Poglitsch has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Marcus D. Säemann, Walter Hermann Hörl, Thomas Weichhart, Maximilian Zeyda, Oliver Domenig, Thomas M. Stulnig, Markus Hengstschläger, Margit Rosner, Mathias M. Müller and Josef Martin Penninger. Their work appears in journals such as Hypertension, Scientific Reports, Journal of Hypertension, Journal of the American Heart Association and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.